Clinical Trials Logo
  1. Home
  2. Neurological Diseases
  3. NCT02790424
  4. Details
NCT02790424 Clinical Trial

Adjustment Exploratory Protocols and Functional Evaluation of New Non Invasive Devices in Patient Volunteers

Neurological Diseases Clinical Trial

— MAP-EFNI PV  

Official title:
Adjustment Exploratory Protocols (MagnetoEncephaloGraphy Study : MEG, ElectroEncephaloGram : EEG, Magnetic Resonance Imaging : MRI, Functional MRI : MRIf, Motor Platform) and Functional Evaluation of New Non Invasive Devices (REX BIONICS Exoskeleton) in Patient Volunteers

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT02790424
Other study ID # MAP-EFNI PV
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date October 22, 2013
Est. completion date October 22, 2021

Study information
Verified date November 2022
Source University Hospital, Grenoble
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Parameters, sequences or paradigms optimisation in view of data quality and relevancy improvement.

Description:

Various tests are needed for methodological optimization of the several devices (per-operative MRI, MEG, EEG, SPECT-CT, motor platform) of the technological platform.

Recruitment information / eligibility
Status Completed
Enrollment 35
Est. completion date October 22, 2021
Est. primary completion date October 22, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Volunteers patient - Male or female aged over 18 years - Registered in the French social security scheme - Signed informed consent Exclusion Criteria: - Contraindication to Magnetoencephalography (MEG) and/or Electroencephalography (EEG) - Contraindication to Magnetic resonance imaging (MRI) - All categories of protected persons

Study Design

Related Conditions & MeSH terms

Intervention

Device:
• Imaging devices
technological adjustment tests

Locations
Country Name City State
France CLINATEC Grenoble

Sponsors (1)
Lead Sponsor Collaborator
University Hospital, Grenoble

Country where clinical trial is conducted

France, 

Outcome
Type Measure Description Time frame Safety issue
Primary Magnetic brain activity MEG records 2 hours
Primary Brain imaging MRI and SPECT-CT records 2 hours
Primary Electrical brain activity EEG records 2 hours
Primary Motor activity parameters Motor platform records 2 hours
See also
  Status Clinical Trial Phase
Completed NCT01371097 - Progressive Resistance Strength Training (PRT) in Hospitalised Elderly Patients N/A
Completed NCT02455284 - In Vivo and ex Vivo Validation of MR Tractography of Brain White Matter Tracts - FIBRATLAS II-III N/A
Recruiting NCT04995848 - Telepalliation - Digital Platform for Patients in Palliation and Their Relatives N/A
Not yet recruiting NCT02340871 - Finding Genes With NGS Techniques in Whom Mutations Cause Neurological Diseases N/A
Completed NCT01783769 - Evaluating the Impact That Personnel Traffic Through the Operating Room Has on Surgical Site Infections N/A
Completed NCT01463995 - Prognosis in Neurological Intensive Care Unit Patients (proNICU Cohort)
Recruiting NCT02018406 - Establishment of Clinical Basis for Hematopoietic Growth Factors Therapy in Brain Injury Phase 1/Phase 2
Terminated NCT00841984 - In Vitro NMR Spectroscopy in Neurological Diseases N/A
Not yet recruiting NCT05515419 - Allogeneic Cord Blood for Neurological Diseases in Adults Early Phase 1
Completed NCT00560157 - Nutritional and Metabolic Evaluation of a Tube Feeding Immune Enhancing Diet in ICU Patients Phase 4
Completed NCT05486052 - Rehabilitation With Biofeedback in Neurology N/A
Recruiting NCT04846764 - Rapid Declarative Neocortical Declarative Learning in Aging and Memory Diseases (ANéRAVIMM) N/A